Concord Biotech IPO GMP Today ( Grey Market Premium )

Concord Biotech IPO GMP Today ( Grey Market Premium )

The Concord Biotech IPO commenced on August 4, 2023, and concluded on August 8, 2023. The allotment of shares took place on August 11, 2023, and the initiation of refunds began on August 14, 2023. The shares were credited to the demat accounts of investors on August 17, 2023. Finally, the listing of Concord Biotech on the stock exchange occurred on August 18, 2023.

The Concord Biotech IPO was priced at ₹00 per share, with a lot size of 00. The total issue size was ₹00 crores, comprising a fresh issue of 00 crores and an offer for sale of ₹00 crores. The IPO was listed on both the NSE and BSE.

In terms of quota reservations, the QIB (Qualified Institutional Buyers) quota was reserved for 50% of the shares, the NII (Non-Institutional Investors) quota was reserved for 15% of the shares, and the retail quota was reserved for 35% of the shares.

Concord Biotech IPO Basic Details

Company NameConcord Biotech Limited
Domain of CompanyIndian Biopharmaceutical Company
Concord Biotech IPO GMP Today₹185
Concord Biotech IPO Listing Gain24.97%
Concord Biotech IPO Open DateAugust 4, 2023
Concord Biotech IPO Close DateAugust 8, 2023
Concord Biotech IPO Allotment DateAugust 11, 2023
Concord Biotech IPO Listing DateAugust 18, 2023
Face Value₹10 per share
Price₹705 to ₹741 per share
Lot Size20 Shares
Issue Size20,925,652 shares
(aggregating up to ₹1,551.00 Cr)
Offer for Sale20,925,652 shares
(aggregating up to ₹1,551.00 Cr)
Issue TypeBook Built Issue IPO
Listing AtNSE, BSE
Company PromotersSudhir Vaid And Ankur Vaid

Concord Biotech IPO GMP Today:

DateGMPListing GainKostakSubject to
16 August 2023₹12216.46%
15 August 2023₹12216.46%
14 August 2023₹12216.46%
13 August 2023₹12216.46%
12 August 2023₹12216.46%
11 August 2023₹12216.46%
10 August 2023₹12216.46%
9 August 2023₹12216.46%
8 August 2023₹12216.46%
7 August 2023₹12216.46%
6 August 2023₹12216.46%
5 August 2023₹12216.46%
4 August 2023₹18825.37%
3 August 2023₹18524.97%
2 August 2023₹18524.97%

Concord Biotech IPO Details:

Established in 1984, Concord Biotech Limited is an Indian biopharmaceutical company driven by research and development. It has earned a prominent position as a global leader in the development and production of fermentation-based Active Pharmaceutical Ingredients (APIs) for immunosuppressants and oncology, based on market share by volume in 2022.

Concord Biotech operates internationally, supplying its products to more than 70 countries, including the USA, India, Europe, and Japan.

The company specializes in manufacturing APIs through fermentation and semi-synthetic processes, as well as finished formulations. What began with a single product has now expanded into a diverse range of solutions, catering to various therapeutic segments.

Concord’s product portfolio includes fermentation and semi-synthetic-based offerings in areas like Immunosuppressants, Anti-bacterial, Oncology, Antifungals, and others, which have garnered a strong customer base worldwide. Additionally, the company maintains an active pipeline of products under development.

Concord Biotech IPO More Details Click Here

Yatharth Hospital IPO FAQs

When is Concord Biotech IPO open?

Concord Biotech IPO will open on 4 August 2023.

When is Concord Biotech IPO Close?

Concord Biotech IPO will be closed on 8 August 2023.

What is Concord Biotech IPO GMP Today?

The Concord Biotech IPO GMP aka Grey Market Premium is ₹122.

What is Concord Biotech IPO Kostak Rates Today?

The Concord Biotech IPO Kostak Rate is ₹000.

What is Concord Biotech IPO Subject to Sauda Price Today?

The Nimbark IPO subject to sauda rates is ₹000.

Concord Biotech IPO Expected Returns?

The Concord Biotech expected return is 16.46%.

How much will be the listing gain in Concord Biotech IPO?

Concord Biotech IPO will get listing gain of 16.46%. (Approx.)

Leave a Reply

Your email address will not be published. Required fields are marked *